About Us

OncoNano Medicine was established to improve the lives of cancer patients.

Our team of scientists, physicians and advisors is pioneering the next frontier of cancer therapeutics using our proprietary nanotechnology platform. OncoNano's ON-BOARD™ platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to maximize the intratumoral delivery of its therapeutic cargoes. OncoNano is passionate about generating a robust oncology pipeline to advance more precise therapies and better patient outcomes.

Leadership

Board of Directors

Brett P. Giroir, MD Chairman 

Chief Executive Officer
Altesa BioSciences

Kartik Krishnan, MD, PhD 

Chief Executive Officer
OncoNano Medicine

Gina Guillem Jones, MMS, PhD 

President
CarGin Enterprises

Benjamin Qui, CFA, CMA

Partner
Advantech/New Horizon Capital

Scientific Advisory Board

Charles Balch, MD, Chairman

Jinming Gao, PhD 

John Niederhuber, MD

Paul Bunn, MD

Baran Sumer, MD

Raphael Pollock, MD, PhD

Alexander Eggermont, MD, PhD